help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0688
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/10/5528    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickey, M.
Right arrow Articles by Salamonsen, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickey, M.
Right arrow Articles by Salamonsen, L. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*ESTROGENIC SUBSTANCES, CONJUGATED
Medline Plus Health Information
*Menopause
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 10 5528-5535
Copyright © 2005 by The Endocrine Society

Menopausal Hormone Therapy and Irregular Endometrial Bleeding: A Potential Role for Uterine Natural Killer Cells?

M. Hickey, J. Crewe, J. P. Goodridge, C. S. Witt, I. S. Fraser, D. Doherty, F. T. Christiansen and L. A. Salamonsen

School of Women’s and Infants’ Health (M.H., J.C., D.D.) and Department of Clinical Immunology and Biochemical Genetics (J.P.G.), Royal Perth Hospital and School of Surgery and Pathology, University of Western Australia, Perth 6008, Western Australia; Department of Clinical Immunology and Biochemical Genetics (C.S.W., F.T.C.), Royal Perth Hospital, Perth 6847, Western Australia; Sydney Centre for Reproductive Health Research (I.S.F.), Family Planning Association Health and Department of Obstetrics and Gynaecology, University of Sydney, Sydney 2006, Australia; and Prince Henry’s Institute of Medical Research (L.A.S.), Melbourne, Victoria 3168, Australia

Address all correspondence and requests for reprints to: Martha Hickey, Associate Professor, School of Women’s and Infants’ Health, King Edward Memorial Hospital, Subiaco, Perth 6008, Western Australia. E-mail: mhickey{at}obsgyn.uwa.edu.au.

Context: Irregular bleeding affects many users of combined menopausal hormone therapy (HT) and commonly leads to invasive and expensive investigations to exclude underlying malignancy. In most cases no abnormality is found.

Objective: The main objective of this study was to explore the role of uterine natural killer (uNK) cells and their regulatory cytokine IL-15 in irregular bleeding in HT users.

Design: This was a prospective observational study conducted between 2002 and 2004.

Setting: The study was conducted in a tertiary referral menopause clinic at King Edward Memorial Hospital, Western Australia.

Patients: Patients included 117 postmenopausal women taking combined HT.

Interventions: Outpatient endometrial biopsies were taken during and outside bleeding episodes.

Main Outcome Measures: The relationship between endometrial uNK cells (CD56+) and bleeding patterns was measured. We also addressed the impact of HT exposure on uNK cell populations, the relationship between endometrial IL-15 expression and uNK cell populations, and killer Ig like receptor genotype in subjects with irregular bleeding.

Results: Endometrial CD56+ uNK cells were significantly increased in biopsies obtained during bleeding episodes (P < 0.001), compared with HT users with no bleeding. The highest level of IL-15 expression was also seen in biopsies taken during bleeding. No clear relationship between killer Ig like receptor genotype and bleeding on HT was observed.

Conclusions: Little is known about the mechanisms underlying irregular bleeding in HT users. This is the first report of uNK cells and their association with regulating cytokines in postmenopausal endometrium and demonstrates a possible mechanism by which HT may induce irregular bleeding.




This article has been cited by other articles:


Home page
Hum ReprodHome page
M. Hickey, D.A. Doherty, I.S. Fraser, D.M. Sloboda, and L.A. Salamonsen
Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels
Hum. Reprod., April 1, 2008; 23(4): 912 - 918.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen
The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women
Reproduction, January 1, 2007; 133(1): 309 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Hickey, J. Crewe, L. A. Mahoney, D. A. Doherty, I. S. Fraser, and L. A. Salamonsen
Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3189 - 3198.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Peloggia, C. A. Petta, L. Bahamondes, M. Oliveira-Ribeiro, J. Zhang, and L. Salamonsen
Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system
Hum. Reprod., May 1, 2006; 21(5): 1129 - 1134.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society